Rafael Holdings, Inc. financial data

Symbol
RFL on NYSE
Industry
Pharmaceutical Preparations
Location
520 Broad Street, Newark, NJ
State of incorporation
DE
Fiscal year end
July 31
Latest financial report
10-Q - Q4 2024 - Mar 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 961 % -76.8%
Debt-to-equity 13.7 % +543%
Return On Equity -61.8 % -2837%
Return On Assets -54.7 % -2575%
Operating Margin -15.2K % -272%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 34.4M USD -51%
Common Stock, Value, Issued 8K USD 0%
Weighted Average Number of Shares Outstanding, Basic 24.2M shares +2.15%
Weighted Average Number of Shares Outstanding, Diluted 24.2M shares -1.03%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 706K USD +157%
Cost of Revenue 38K USD
Research and Development Expense 5.34M USD +71.9%
General and Administrative Expense 9.37M USD +12.3%
Operating Income (Loss) -107M USD -854%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -84.3M USD -3806%
Income Tax Expense (Benefit) 20K USD
Net Income (Loss) Attributable to Parent -50.5M USD -2403%
Earnings Per Share, Basic -2.12 USD/shares -2220%
Earnings Per Share, Diluted -2.11 USD/shares -2444%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 48.3M USD +577%
Accounts Receivable, after Allowance for Credit Loss, Current 200K USD
Assets, Current 65.8M USD -12.3%
Property, Plant and Equipment, Net 1.93M USD -6.35%
Intangible Assets, Net (Excluding Goodwill) 1.79M USD -5.35%
Goodwill 3.05M USD
Other Assets, Noncurrent 20K USD -52.4%
Assets 83M USD -21.8%
Accounts Payable, Current 2.55M USD +400%
Accrued Liabilities, Current 1.41M USD +67.1%
Liabilities, Current 7.11M USD +118%
Deferred Income Tax Liabilities, Net 73K USD
Other Liabilities, Noncurrent 5K USD -90.9%
Liabilities 10.5M USD +169%
Retained Earnings (Accumulated Deficit) -215M USD -30.6%
Stockholders' Equity Attributable to Parent 69.4M USD -33.9%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 72.6M USD -29%
Liabilities and Equity 83M USD -21.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.04M USD -42.6%
Net Cash Provided by (Used in) Financing Activities -48K USD -106%
Net Cash Provided by (Used in) Investing Activities 8.58M USD
Common Stock, Shares, Issued 3.97M shares
Common Stock, Par or Stated Value Per Share 0.63 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 5.48M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 48.3M USD +577%
Deferred Tax Assets, Valuation Allowance 71.3M USD +40.1%
Deferred Tax Assets, Gross 71.4M USD +40.3%
Payments to Acquire Property, Plant, and Equipment 6K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -50.2M USD -2973%
Lessee, Operating Lease, Liability, to be Paid 526K USD +353%
Property, Plant and Equipment, Gross 3.03M USD +1.78%
Lessee, Operating Lease, Liability, to be Paid, Year Two 188K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 181K USD +132%
Lessee, Operating Lease, Liability, to be Paid, Year Three 78K USD
Deferred Tax Assets, Operating Loss Carryforwards 61.2M USD +243%
Unrecognized Tax Benefits 6.22M USD
Additional Paid in Capital 264M USD +3.38%
Amortization of Intangible Assets 39K USD +225%
Depreciation, Depletion and Amortization 17K USD -22.7%
Deferred Tax Assets, Net of Valuation Allowance 2.36M USD -95.4%
Share-based Payment Arrangement, Expense 1.79M USD -28.1%
Operating Leases, Future Minimum Payments Due 155K USD -10.9%
Interest Expense 163K USD